Victory Capital Management’s Abiomed Inc ABMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-8,064	Closed	-$1.98M	–	2759
2022 Q3	$1.98M	Sell	8,064 -14,111	-64%	-$3.81M	﹤0.01%	1453
2022 Q2	$5.49M	Sell	22,175 -328	-1%	-$88.5K	0.01%	1226
2022 Q1	$6.45M	Buy	22,503 +1,659	+8%	+$511K	0.01%	1248
2021 Q4	$7.49M	Sell	20,844 -79	-0.4%	-$26.7K	0.01%	1213
2021 Q3	$6.81M	Sell	20,923 -531	-2%	-$180K	0.01%	1225
2021 Q2	$6.7M	Sell	21,454 -27,264	-56%	-$8.36M	0.01%	1247
2021 Q1	$15.5M	Buy	48,718 +2,114	+5%	+$677K	0.02%	1000
2020 Q4	$15.1M	Sell	46,604 -14,921	-24%	-$4.13M	0.02%	986
2020 Q3	$17M	Buy	61,525 +46,973	+323%	+$13.5M	0.02%	873
2020 Q2	$3.52M	Sell	14,552 -12,890	-47%	-$2.59M	﹤0.01%	1259
2020 Q1	$3.98M	Buy	27,442 +10,239	+60%	+$1.7M	﹤0.01%	1339
2019 Q4	$2.94M	Sell	17,203 -185,946	-92%	-$34.5M	﹤0.01%	1363
2019 Q3	$36.1M	Buy	203,149 +104,400	+106%	+$22.6M	0.05%	570
2019 Q2	$25.7M	Sell	98,749 -108,053	-52%	-$28.7M	0.05%	525
2019 Q1	$59.1M	Buy	206,802 +48,771	+31%	+$16.2M	0.13%	220
2018 Q4	$51.4M	Sell	158,031 -15,408	-9%	-$5.35M	0.13%	229
2018 Q3	$78M	Buy	173,439 +37,948	+28%	+$15M	0.16%	162
2018 Q2	$55.4M	Buy	135,491 +45,188	+50%	+$16.4M	0.12%	262
2018 Q1	$26.3M	Buy	90,303 +79,326	+723%	+$20.1M	0.06%	507
2017 Q4	$2.06M	Buy	10,977 +1,237	+13%	+$231K	﹤0.01%	1020
2017 Q3	$1.64M	Sell	9,740 -21	-0.2%	-$3.17K	﹤0.01%	1063
2017 Q2	$1.4M	Buy	9,761 +1,738	+22%	+$234K	﹤0.01%	1081
2017 Q1	$1M	Buy	8,023 +3,009	+60%	+$349K	﹤0.01%	1171
2016 Q4	$565K	Buy	5,014 +584	+13%	+$67.7K	﹤0.01%	1257
2016 Q3	$570K	Buy	+4,430	New	+$531K	﹤0.01%	1221

Other funds holding ABMD